Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up-A Single Center Experience.
Borlenghi E, Cattaneo C, Bertoli D, Cerqui E, Archetti S, Passi A, Oberti M, Zollner T, Giupponi C, Pagani C, Bianchetti N, Bottelli C, Bagnasco S, Sciumè M, Tucci A, Rossi G. Borlenghi E, et al. Among authors: archetti s. Cancers (Basel). 2022 Sep 28;14(19):4716. doi: 10.3390/cancers14194716. Cancers (Basel). 2022. PMID: 36230640 Free PMC article.
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Borlenghi E, Cattaneo C, Cerqui E, Archetti S, Bertoli D, Bellotti D, Gramegna D, Soverini G, Oberti M, Schieppati F, Pagani C, Passi A, Sciumé M, Farina M, Carbone C, Crippa C, Dalceggio D, Tucci A, Rossi G. Borlenghi E, et al. Among authors: archetti s. Hematol Oncol. 2020 Dec;38(5):754-762. doi: 10.1002/hon.2806. Epub 2020 Sep 29. Hematol Oncol. 2020. PMID: 32950042
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D, Bertoli D, Cattaneo C, Almici C, Re A, Belotti A, Borlenghi E, Lanzi G, Archetti S, Verardi R, Brugnoni D, Sciumè M, Daffini R, Roccaro AM, Tucci A, Rossi G. Gramegna D, et al. Among authors: archetti s. Ann Hematol. 2022 Jun;101(6):1227-1237. doi: 10.1007/s00277-022-04806-x. Epub 2022 Apr 5. Ann Hematol. 2022. PMID: 35380239
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?
Giupponi C, Bertoli D, Borlenghi E, Cattaneo C, Zollner T, Masina L, Bagnasco S, Cerqui E, Federico F, Pagani C, Archetti S, Brugnoni D, Rossi G, Tucci A. Giupponi C, et al. Among authors: archetti s. Blood Cancer J. 2023 Dec 21;13(1):194. doi: 10.1038/s41408-023-00959-8. Blood Cancer J. 2023. PMID: 38129393 Free PMC article. No abstract available.
P-Tau as prognostic marker in long term follow up for patients with shunted iNPH.
Migliorati K, Panciani PP, Pertichetti M, Borroni B, Archetti S, Rozzini L, Padovani A, Terzi L, Bruscella S, Fontanella MM. Migliorati K, et al. Among authors: archetti s. Neurol Res. 2021 Jan;43(1):78-85. doi: 10.1080/01616412.2020.1831300. Epub 2020 Oct 15. Neurol Res. 2021. PMID: 33059546
Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia.
Gazzina S, Grassi M, Premi E, Alberici A, Benussi A, Archetti S, Gasparotti R, Bocchetta M, Cash DM, Todd EG, Peakman G, Convery RS, van Swieten JC, Jiskoot LC, Seelaar H, Sanchez-Valle R, Moreno F, Laforce R Jr, Graff C, Synofzik M, Galimberti D, Rowe JB, Masellis M, Tartaglia MC, Finger E, Vandenberghe R, de Mendonça A, Tagliavini F, Butler CR, Santana I, Gerhard A, Ber IL, Pasquier F, Ducharme S, Levin J, Danek A, Sorbi S, Otto M, Rohrer JD, Borroni B; Genetic Frontotemporal dementia Initiative (GENFI). Gazzina S, et al. Among authors: archetti s. Neurobiol Aging. 2022 Jun;114:94-104. doi: 10.1016/j.neurobiolaging.2022.02.009. Epub 2022 Feb 26. Neurobiol Aging. 2022. PMID: 35339292
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia.
Cosseddu M, Benussi A, Gazzina S, Turrone R, Archetti S, Bonomi E, Biasiotto G, Zanella I, Ferrari R, Cotelli MS, Alberici A, Padovani A, Borroni B. Cosseddu M, et al. Among authors: archetti s. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):87-92. doi: 10.1080/21678421.2017.1384020. Epub 2017 Oct 8. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 28990425
Serum neurofilament light in professional soccer players: goal on safety.
Cornali C, Amaddeo P, Benussi A, Perrone F, Manes M, Zanardini R, Benussi L, Belotti F, Bellini G, Bruzzone A, Bruzzone M, Morelli D, Archetti S, Latronico N, Padovani A, Fontanella MM, Ghidoni R, Borroni B. Cornali C, et al. Among authors: archetti s. Neurol Sci. 2022 Aug;43(8):5087-5090. doi: 10.1007/s10072-022-06109-5. Epub 2022 May 18. Neurol Sci. 2022. PMID: 35583840
Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease.
Benussi A, Cantoni V, Grassi M, Brechet L, Michel CM, Datta A, Thomas C, Gazzina S, Cotelli MS, Bianchi M, Premi E, Gadola Y, Cotelli M, Pengo M, Perrone F, Scolaro M, Archetti S, Solje E, Padovani A, Pascual-Leone A, Borroni B. Benussi A, et al. Among authors: archetti s. Ann Neurol. 2022 Aug;92(2):322-334. doi: 10.1002/ana.26411. Epub 2022 Jun 6. Ann Neurol. 2022. PMID: 35607946 Free PMC article. Clinical Trial.
Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype.
Katisko K, Huber N, Kokkola T, Hartikainen P, Krüger J, Heikkinen AL, Paananen V, Leinonen V, Korhonen VE, Helisalmi S, Herukka SK, Cantoni V, Gadola Y, Archetti S, Remes AM, Haapasalo A, Borroni B, Solje E. Katisko K, et al. Among authors: archetti s. Alzheimers Res Ther. 2022 Oct 11;14(1):151. doi: 10.1186/s13195-022-01091-8. Alzheimers Res Ther. 2022. PMID: 36217158 Free PMC article.
192 results